Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy.
D000042:Absorption; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000378:metabolism; D003925:Diabetic Angiopathies / Q000517:prevention & control; D016883:Diabetic Ketoacidosis / Q000209:etiology; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism; D007331:Insulin Coma / Q000209:etiology; D007332:Insulin Infusion Systems / Q000009:adverse effects; D007700:Kinetics; D012039:Regional Blood Flow
D001786:Blood Glucose; D007328:Insulin